呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2020 共识声明：免疫功能低下者成人社区获得性肺炎的初始治疗策略

2020-11-20 国外呼吸科专家组（统称） Chest.2020 Nov;158(5):1896-1911.

社区获得性肺炎

社区获得性肺炎（CAP）指南主要通过规范初始经验性治疗改善了CAP患者的治疗和预后，但针对免疫功能低下者的CAP却没有相关指导。本文主要针对免疫功能低下者成人社区获得性肺炎的初始治疗提供指导建议。

中文标题：

2020 共识声明：免疫功能低下者成人社区获得性肺炎的初始治疗策略

英文标题：

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies

发布机构：

国外呼吸科专家组（统称）

发布日期：

2020-11-20

简要介绍：

社区获得性肺炎（CAP）指南主要通过规范初始经验性治疗改善了CAP患者的治疗和预后，但针对免疫功能低下者的CAP却没有相关指导。本文主要针对免疫功能低下者成人社区获得性肺炎的初始治疗提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 共识声明：免疫功能低下者成人社区获得性肺炎的初始治疗策略.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5ad3e1c002103ac8, title=2020 共识声明：免疫功能低下者成人社区获得性肺炎的初始治疗策略, enTitle=Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies, guiderFrom=Chest.2020 Nov;158(5):1896-1911., authorId=0, author=, summary=社区获得性肺炎（CAP）指南主要通过规范初始经验性治疗改善了CAP患者的治疗和预后，但针对免疫功能低下者的CAP却没有相关指导。本文主要针对免疫功能低下者成人社区获得性肺炎的初始治疗提供指导建议。, cover=https://img.medsci.cn/2021520/1621520206258_2020535.jpg, journalId=0, articlesId=null, associationId=1219, associationName=国外呼吸科专家组（统称）, associationIntro=国外呼吸科专家组（统称）, copyright=0, guiderPublishedTime=Fri Nov 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>社区获得性肺炎（CAP）指南主要通过规范初始经验性治疗改善了CAP患者的治疗和预后，但针对免疫功能低下者的CAP却没有相关指导。本文主要针对免疫功能低下者成人社区获得性肺炎的初始治疗提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1280, tagName=社区获得性肺炎)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1280, guiderKeyword=社区获得性肺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3217, appHits=247, showAppHits=0, pcHits=685, showPcHits=2967, likes=1, shares=21, comments=12, approvalStatus=1, publishedTime=Thu May 20 23:18:50 CST 2021, publishedTimeString=2020-11-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu May 20 22:16:58 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 21:19:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 共识声明：免疫功能低下者成人社区获得性肺炎的初始治疗策略.pdf)])
2020 共识声明：免疫功能低下者成人社区获得性肺炎的初始治疗策略.pdf
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1183278, encodeId=013c11832e85e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Tue Jan 11 17:18:45 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076491, encodeId=e56a10e649191, content=没有中文版吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Fri Dec 03 10:12:19 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067825, encodeId=69fb106e82537, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c885608113, createdName=ms3000000904619767, createdTime=Sun Nov 07 16:50:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053579, encodeId=ea1e10535e971, content=内容实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f5612476, createdName=ms8000000969769840, createdTime=Tue Sep 21 21:45:31 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006829, encodeId=988b100682906, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84995224884, createdName=1478a36dm32(暂无昵称), createdTime=Wed Aug 11 06:16:21 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2022-01-11 gujie_happy

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1183278, encodeId=013c11832e85e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Tue Jan 11 17:18:45 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076491, encodeId=e56a10e649191, content=没有中文版吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Fri Dec 03 10:12:19 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067825, encodeId=69fb106e82537, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c885608113, createdName=ms3000000904619767, createdTime=Sun Nov 07 16:50:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053579, encodeId=ea1e10535e971, content=内容实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f5612476, createdName=ms8000000969769840, createdTime=Tue Sep 21 21:45:31 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006829, encodeId=988b100682906, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84995224884, createdName=1478a36dm32(暂无昵称), createdTime=Wed Aug 11 06:16:21 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-12-03 moyanju2796

    没有中文版吗？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1183278, encodeId=013c11832e85e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Tue Jan 11 17:18:45 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076491, encodeId=e56a10e649191, content=没有中文版吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Fri Dec 03 10:12:19 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067825, encodeId=69fb106e82537, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c885608113, createdName=ms3000000904619767, createdTime=Sun Nov 07 16:50:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053579, encodeId=ea1e10535e971, content=内容实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f5612476, createdName=ms8000000969769840, createdTime=Tue Sep 21 21:45:31 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006829, encodeId=988b100682906, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84995224884, createdName=1478a36dm32(暂无昵称), createdTime=Wed Aug 11 06:16:21 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-11-07 ms3000000904619767

    非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1183278, encodeId=013c11832e85e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Tue Jan 11 17:18:45 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076491, encodeId=e56a10e649191, content=没有中文版吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Fri Dec 03 10:12:19 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067825, encodeId=69fb106e82537, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c885608113, createdName=ms3000000904619767, createdTime=Sun Nov 07 16:50:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053579, encodeId=ea1e10535e971, content=内容实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f5612476, createdName=ms8000000969769840, createdTime=Tue Sep 21 21:45:31 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006829, encodeId=988b100682906, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84995224884, createdName=1478a36dm32(暂无昵称), createdTime=Wed Aug 11 06:16:21 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-09-21 ms8000000969769840

    内容实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1183278, encodeId=013c11832e85e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Tue Jan 11 17:18:45 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076491, encodeId=e56a10e649191, content=没有中文版吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbcd5675699, createdName=moyanju2796, createdTime=Fri Dec 03 10:12:19 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067825, encodeId=69fb106e82537, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c885608113, createdName=ms3000000904619767, createdTime=Sun Nov 07 16:50:11 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053579, encodeId=ea1e10535e971, content=内容实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c63f5612476, createdName=ms8000000969769840, createdTime=Tue Sep 21 21:45:31 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006829, encodeId=988b100682906, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84995224884, createdName=1478a36dm32(暂无昵称), createdTime=Wed Aug 11 06:16:21 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 1478a36dm32(暂无昵称)

    非常好

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

中医药单用/联合抗生素治疗社区获得性肺炎临床实践指南

中华中医药学会(CACM,China Association of Chinese Medcine) · 2021-02-20

成人社区获得性肺炎基层合理用药指南

中华医学会(CMA,Chinese Medical Association) · 2020-09-25

社区获得性肺炎中医诊疗指南（2018修订版）

中华中医药学会(CACM,China Association of Chinese Medcine) 内科分会 · 2019-02-20

2018 社区获得性肺炎管理建议

国外呼吸科专家组（统称） · 2018-09-30

南非成人社区获得性肺炎管理指南

暂未更新 · 2017-11-30

2015 社区获得性肺炎中西医综合治疗指南（2015年上海市基层版）

中国呼吸科专家组（统称） · 2016-07-15

拓展阅读

2009 ACEP临床决策：成人社区获得性肺炎患者急诊评估与治疗的关键问题

美国急诊医师学会(ACEP,American College of Emergency Physicians) · 2009-11-01

2011IDSA/PIDS 美国3个月以上婴儿和儿童社区获得性肺炎的管理

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2011-08-30

2011PIDS/IDSA 美国婴儿及＞3个月儿童的社区获得性肺炎（CAP）处理指南

儿童感染病协会(PIDS,the Pediatric Infectious Diseases Society) · 2011-08-30

2011 中国急诊成人社区获得性肺炎诊治专家共识（一）

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2011-10-01

2011 BTS儿童社区获得性肺炎诊治指南

英国胸科协会(BTS,British Thoracic Society) · 2011-10-01

社区获得性肺炎中医诊疗指南（2011版）

中华中医药学会内科分会肺系病专业委员会 · 2011-11-01